Fred B. Craves - Jun 25, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Stock symbol
MDGL
Transactions as of
Jun 25, 2024
Transactions value $
$0
Form type
4
Date filed
6/27/2024, 09:46 PM
Previous filing
Jun 13, 2024
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Award $0 +714 +0.19% $0.00 375K Jun 25, 2024 Direct F1
holding MDGL Common Stock 11.2K Jun 25, 2024 See Footnote F2
holding MDGL Common Stock 1.26K Jun 25, 2024 See Footnote F3
holding MDGL Common Stock 18K Jun 25, 2024 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Award $0 +1.11K $0.00 1.11K Jun 25, 2024 Common Stock 1.11K $280.04 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest on June 25, 2025, provided the Reporting Person continues in service with the Issuer on such date.
F2 Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
F3 These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.
F4 Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.
F5 The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.